KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer
Yohei Sekino(Hiroshima University), Wataru Yasui(Hiroshima University)
Cited by 55
Related Papers
Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer
|Cancer Science|2008|52
Claspin overexpression is associated with high‐grade histology and poor prognosis in renal cell carcinoma
|Cancer Science|2020|48
PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma
|Anticancer Research|2020|31